David Hamilton is the founder and CEO of BPX.AI, a consulting firm with investment for pharma, biotech, medtech, and AI. Since founding BPX in 2019, they have grown the team to 35+ life sciences experts and lead strategic consulting, AI solutions, and venture-building services for biopharma companies. They bring two decades of pharmaceutical development and technology innovation experience, including roles at Novartis Oncology (Business Operations Manager, 2016) and as Associated Director, Clinical Development, Strategy & Operations (2012–2014), as well as an earlier tenure at Schering-Plough Research Institute (Assistant Scientist, 2006–2009). They also co-founded CrystlCrypto (2021–2023).
This person is not in the org chart
This person is not in any teams
This person is not in any offices